Literature DB >> 23198843

Successful rheolytic mechanical thrombectomy of cerebral venous thrombosis in a pediatric patient.

Stylianos K Rammos1, Jayme Phillips, Julian Lin, Kenneth Moresco, Sean Meagher.   

Abstract

Thrombosis of the deep cerebral venous system is associated with a significant risk of morbidity and mortality in the pediatric population. Anticoagulation is the mainstay of current treatment of cerebral venous thrombosis (CVT). Systemic or local delivery of thrombolytics may be used in cases of inexorable progression of CVT and neurological compromise. Mechanical thrombectomy has been described in adult patients with CVT and may offer the added advantage of accelerated thrombolysis in the face of rapid clinical deterioration. In this report the authors describe the use of rheolytic mechanical thrombectomy in a pediatric patient with extensive dural sinus and deep CVT.

Entities:  

Mesh:

Year:  2012        PMID: 23198843     DOI: 10.3171/2012.11.PEDS12176

Source DB:  PubMed          Journal:  J Neurosurg Pediatr        ISSN: 1933-0707            Impact factor:   2.375


  4 in total

Review 1.  How I treat pediatric venous thromboembolism.

Authors:  Guy Young
Journal:  Blood       Date:  2017-08-03       Impact factor: 22.113

2.  Dural sinus mechanical thrombectomy and continuous local rt-PA infusion in a child with refractory intracranial hypertension and progressive visual loss: A case report.

Authors:  Martino Cellerini; Rosa Francavilla; Caterina Testoni; Monica Maffei; Mino Zucchelli; Chiara Ghizzi
Journal:  Surg Neurol Int       Date:  2020-08-21

3.  Combined use of Solitaire FR and Penumbra devices for endovascular treatment of cerebral venous sinus thrombosis in a child.

Authors:  Hamza Shaikh; Bryan Anthony Pukenas; Adeka McIntosh; Daniel Licht; Robert W Hurst
Journal:  BMJ Case Rep       Date:  2014-02-19

Review 4.  New Developments in the Pathophysiology, Workup, and Diagnosis of Dural Venous Sinus Thrombosis (DVST) and a Systematic Review of Endovascular Treatments.

Authors:  Sanjay Konakondla; Clemens M Schirmer; Fengwu Li; Xiaogun Geng; Yuchuan Ding
Journal:  Aging Dis       Date:  2017-04-01       Impact factor: 6.745

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.